GeneralConnection.com ➔ Dictionary
Dictionary Search

dosed

Synonyms

Adjective

1. treated

Usage
California man dosed sons daily with hallucinogens, ran psilocybin operation: prosecutors - WANE 15
First patient dosed in Axsome’s FOCUS-3 trial of solriamfetol for ADHD - Yahoo
SoCal man dosed his kids with hallucinogenic mushrooms every day - Los Angeles Times
REGENXBIO doses first patient in eye-disease gene therapy trial - Stock Titan
First patient dosed in Racura’s HARNESS-1 trial of RC220 - Clinical Trials Arena
California father pleads guilty to dosing children with psychedelic mushrooms, federal prosecutors say - Courthouse News
EyeWorld Weekly, June 26, 2026 - EyeWorld
AriBio completes main phase 3 dosing for oral Alzheimer's drug AR1001, topline data due this fall - koreabiomed.com
First patient dosed in phase 3 pivotal cohort of LIGHTHOUSE trial evaluating ATSN-201 for X-linked retinoschisis - Ophthalmology Times
Mediar Therapeutics Announces First Cohorts Dosed in Phase 1 Clinical Trial of MTX-439 for Fibrosis Associated with Chronic Kidney Disease (CKD) and Additions to Clinical Advisory Board - PR Newswire
California dad admits dosing his children hallucinogenic mushrooms every other day - The Independent
First participant dosed in pioneering neural stem cell trial for Huntington’s disease - HDBuzz
Fallbrook father pleads guilty after dosing his kids with hallucinogenic mushrooms, selling them - fox5sandiego.com
Comparative Effectiveness of Rituximab Dosed Every 6 and 12 Months in Relapsing Multiple Sclerosis - Neurology® Journals
San Diego man pleads guilty to dosing his kids with ‘magic mushrooms’ - New York Post
DiaMedica Therapeutics Announces First Patients Dosed in Phase 2 Trial of DM199 for the Treatment of Fetal Growth Restriction - BioSpace
First Huntington’s patient dosed in large trial of oral therapy votoplam - huntingtonsdiseasenews.com
Dosed - Dosed | OFFICIAL TRAILER [HD] - IMDb
First patient dosed in Deciphera’s Phase III INTREPID study - Clinical Trials Arena
First Patient Dosed with Azenosertib in Aspenova Phase III Trial for Treatment of Ovarian Cancer - Applied Clinical Trials Online
First human dosed with cellular reprogramming drug in longevity trial - Washington Times
CytoDyn Announces First Patient Dosed in Phase 2a Study in Collaboration with Weill Cornell Medicine Evaluating Leronlimab in Alzheimer’s Disease - CytoDyn Inc.
First patient dosed in CatalYm’s Phase IIb visugromab trial - Clinical Trials Arena
PleoPharma, Inc. Announces First Patient Dosed in Pivotal Phase 3 Clinical Trial of PP-01 (CAN-004) for Mitigation of Cannabis Withdrawal Symptoms in Patients with Cannabis Use Disorder - Morningstar
Atom Therapeutics Announces First Patient Dosed in China Phase 3 Clinical Trial of Lingdolinurad (ABP-671) for Chronic Gout - Business Wire
Verrica Pharmaceuticals Announces First U.S. Patient Dosed - GlobeNewswire
Deciphera Pharmaceuticals Announces First Patient Dosed in Pivotal Phase 3 INTREPID Study of Sapablursen in Polycythemia Vera - BioSpace
AvenCell Therapeutics Announces First Patient Dosed in Phase I QUADvance Study with AVC-203, a Novel Allogeneic CD19/CD20 Dual-Targeting CAR-T Investigational Therapy for the Treatment of Relapsed/Refractory B-Cell Malignancies - PR Newswire
First patient dosed in Merck’s Phase III PROCEADE-CRC-03 trial for mCRC - Clinical Trials Arena
FibroBiologics Announces First Patients Dosed in Phase 1/2 - GlobeNewswire
CytoDyn Announces First Patient Dosed in Expanded Access Program for Leronlimab in Triple-Negative Breast Cancer - CytoDyn Inc.
First patient dosed in Newleos’ Phase Ib trial of NTX-2001 - Clinical Trials Arena
Elevar Therapeutics Announces First Patients Dosed in Phase - GlobeNewswire
Ventus Therapeutics Announces First Patient Dosed in Phase 2 Clinical Trial of VENT-03, a Novel Small Molecule cGAS Inhibitor, in Patients with Lupus - Ventus Therapeutics
First patient dosed in phase I/II trial of complement-targeting gene therapy for geographic atrophy - Ophthalmology Times
GEMMABio Announces First Patient Dosed in CHARISMA Trial of GB221, Investigational Next‑Generation Gene Therapy for Spinal Muscular Atrophy Type 1 (SMA1) - PR Newswire
Unravel Biosciences Announces First Patient Dosed in RVL-001 Proof of Concept Studies for Rett Syndrome and Pitt Hopkins Syndrome - Business Wire
GentiBio Announces First Participant Dosed in POLARIS Phase 1 Clinical Trial of GNTI-122 in Recently Diagnosed Type 1 Diabetes - PR Newswire
First Patient Dosed in JANX014 Trial in Metastatic CRPC - Targeted Oncology
First patient dosed with CRISPR HBV silencer - CRISPR Medicine News
Repertoire Immune Medicines Announces First Participant Dosed in Phase 1/2 Trial of RPTR-1-201, a T Cell-Targeted Immune Medicine for Advanced Solid Tumors - PR Newswire
First participant dosed in Jade’s Phase II JUNIPER trial for IgAN - Clinical Trials Arena
First boys dosed in Phase 2 trial of oral DMD treatment SAT-3247 - Muscular Dystrophy News
First Patient Dosed in VIR-5500 T-Cell Engager Trial in Metastatic Prostate Cancer - Targeted Oncology
Biogen and Stoke Therapeutics Announce First Patient Dosed in Phase 3 EMPEROR Study of Zorevunersen, a Potential Disease-Modifying Treatment for Dravet Syndrome - Biogen
Perspective Therapeutics Announces First Patients Dosed in New Cohorts of Two Ongoing Phase 1/2a Studies - Yahoo Finance
First patient dosed in LOPD gene therapy trial - Pompe Disease News
Quetzal Therapeutics Announces First Patient Dosed in Phase - GlobeNewswire
Immunome Announces First Patient Dosed in Phase 1 Trial Evaluating IM-1617, a Potential First-in-Class ADC, in Patients with Advanced Solid Tumors - Business Wire
GT Biopharma Announces First Patient Dosed in Phase 1 Trial - GlobeNewswire
Perspective Therapeutics Expands Therapeutic Focus Areas; First Patient Dosed with [212Pb]VMT-α-NET in the Meningioma Cohort of a Phase 1/2a Study - Yahoo Finance
Sapu Nano Announces First Patient Dosed in Phase 1b Trial - GlobeNewswire
AVEO Oncology, an LG Chem company, Announces First Patient Dosed in Front-Line AML Combination Study of Ficlatuzumab - PR Newswire
Iterion Therapeutics Expands Clinical Development of Tegavivint, a First-in-Class Wnt/β-Catenin Inhibitor, into Colorectal Cancer with First Patient Dosed - PR Newswire
Mestag Therapeutics Announces the First Patient Dosed with MST-0312 in the Phase I STARLYS Trial - GlobeNewswire
First U.S. Patient Dosed in BiPASS: Phase 3 Prostate Cancer Diagnosis Study - PR Newswire
Alkeus Pharmaceuticals Announces First Patient Dosed in - GlobeNewswire
Innovent Biologics Announces First Patient Dosed in a Phase 3 Clinical Trial of IBI3003(GPRC5D/BCMA/CD3 Tri-specific Antibody) for the Treatment of Multiple Myeloma - Yahoo Finance
Iterion Therapeutics Announces First Patient Dosed in Clinical Study of Tegavivint, a First-in-Class Wnt/β-Catenin Inhibitor, in Relapsed/Refractory Osteosarcoma - PR Newswire
SOFIE Biosciences Announces First Patient Dosed in [18F]FAPI-74 Phase 3 Study for Pancreatic Cancer - PR Newswire
First participants dosed in new POINT-HD huntingtin-lowering trial - HDBuzz
Definium Therapeutics Announces First Patient Dosed in Ascend, the Second Phase 3 Pivotal Study of DT120 ODT in Major Depressive Disorder - Business Wire
InnoCare Announces First Patient Dosed in Phase III Trial of Orelabrutinib for SLE - GlobeNewswire
Hope Medicine Announces First Patient Dosed in the Phase III Clinical Trial for Endometriosis - BioSpace
NRG Therapeutics Announces First Participants Dosed in its - GlobeNewswire
AIRNA Announces First Patient Dosed in Phase 1 Trial of AIR-001, Potential Best-in-Class RNA-Editing Therapy for Alpha-1 Antitrypsin Deficiency (AATD) - BioSpace
GRIN Therapeutics Announces First Patient Dosed in Global Phase 3 Beeline Trial of Investigational Radiprodil for GRIN-Related Neurodevelopmental Disorder - PR Newswire
Invivyd Announces First Participants Dosed in LIBERTY, a Phase 3 Clinical Trial to Evaluate the Safety and Tolerability of VYD2311 Antibody Versus mRNA COVID Vaccine and to Characterize the Safety and Immunology of Antibody and mRNA Vaccine Co-A - Yahoo Finance
Qurient Announces First Patient Dosed in Phase 2 Trial of Novel CDK7 Inhibitor Mocaciclib (Q901) for the treatment of HR-Positive Breast Cancer - Business Wire
iRegene Hits Dual Global Firsts: U.S. Patient Dosed in Phase IIa for NouvNeu001 in Parkinson’s and First Enrollment in China’s Randomized MSA Trial for NouvNeu004 - Fierce Biotech
Milestone Alert: First Patient Dosed in Phase 3 Trial of Orelabrutinib for SLE - The Dermatology Digest
First Patient Dosed in New Study Investigating Novel Made-In-Canada Drug Candidate to Prevent Brain Injury in Hemodialysis Patients - Business Wire
Hinge Bio Announces First Subject Dosed in Phase 1 Trial of - GlobeNewswire
Ukko Announces First Participant Dosed in Phase 1/2a Clinical Study Evaluating UKK-0018 for Peanut Allergy Treatment - BioSpace
Janux Therapeutics Announces First Participant Dosed in Phase 1 Study of JANX014 - Business Wire
EnGeneIC Announces First Patient Dosed in Recurrent Glioblastoma Clinical Trial - GlobeNewswire
Zentalis Pharmaceuticals Announces First Patient Dosed in - GlobeNewswire
Crystalys Therapeutics Expands Phase 3 RUBY Study With First Patients Dosed at European Sites - PR Newswire
Aplagon Announces First Patient Dosed in Phase 2a Clinical - GlobeNewswire
Tiziana Announces Last Patient Successfully Dosed in its Phase 2 INFORM-MS Trial - NTB Kommunikasjon
Life Biosciences Announces First Patient Dosed in Phase 1 Trial of ER‑100 for Optic Neuropathies - GlobeNewswire
iBio Becomes a Clinical-Stage Company with First Participant Dosed in Phase 1 Clinical Trial of IBIO-600 in Adults with Obesity - Yahoo Finance
GlycoNex Announces Last Patient Dosed in Phase 3 Trial of SPD8, a Denosumab Biosimilar for Osteoporosis - PR Newswire
Biomea Fusion Announces First Patient Dosed in Newly Initiated Phase II Programs Enrolling Type 2 Diabetes Patients Failing on Standard-of-Care Therapies - Yahoo Finance
Kali Therapeutics Announces First Patient Dosed in Phase 1a Clinical Trial of KT501 for Rheumatoid Arthritis - BioSpace
Merck Announces First Patient Dosed in Phase 3 Study for Investigational Antibody-Drug Conjugate in Colorectal Cancer - Business Wire
Development and validation of a machine learning model for individualised meropenem dosing in CRRT patients - Nature
BioLineRx and Hemispherian Announce First Patient Dosed in Phase 1/2a Study of GLIX1 for the Treatment of Glioblastoma (GBM) - Yahoo Finance
Neomorph Announces First Patient Dosed in Phase 1/2 Trial - GlobeNewswire
Biocytogen Announces Clinical Milestone with First Patient Dosed in Phase 1 Trial of IDEAYA’s First-in-Class B7H3/PTK7 Bispecific TOP1 ADC IDE034 - Business Wire
Pliant Therapeutics Announces First Patient Dosed in - GlobeNewswire
GE HealthCare Announces First Patient Dosed in Phase 2/3 LUMINA Trial for Manganese-Based MRI Contrast Agent Under FDA Fast Track Designation, Further Advancing Its Innovation Pipeline of Novel Imaging Agents - Business Wire
First Participant Dosed in AskBio Phase 1/Phase 2 Gene - GlobeNewswire
Jade Biosciences Announces First Participant Dosed in Phase 2 JUNIPER Clinical Trial of JADE101 in IgA Nephropathy - GlobeNewswire
HAYA Therapeutics Announces First Cohort Dosed in Phase 1 Clinical Trial of HTX-001, an Investigational Precision Cellular Reprogramming Therapy for Cardiac Fibrosis - Business Wire
daptomycin dosing antibiotics Critical Care Congress SCCM 2026 - Infectious Disease Special Edition
Ratio Therapeutics has Successfully Dosed the First Cohort in its Phase 1/2 Study Evaluating a Novel FAP-Targeted Radiopharmaceutical in Patients with Late-Stage Aggressive Sarcomas - PR Newswire
BioAge Labs Announces First Participant Dosed in QUELL-CV, a Phase 2 Proof-of-Concept Trial of BGE-102, a Novel Oral NLRP3 Inhibitor, in Patients at Elevated Cardiovascular Risk - Yahoo! Finance Canada
Biotheryx Announces First Patient Dosed in the Dose Expansion Phase of BTX-9341-101 for the Treatment of HR+/HER2- Breast Cancer - PR Newswire
Zentalis Pharmaceuticals Announces First Patient Dosed in ASPENOVA Phase 3 Trial of Azenosertib in Patients with Cyclin E1-Positive Platinum-Resistant Ovarian Cancer - Yahoo Finance
Foreign Language Equivalents
Foreign Language Equivalents of 'dosed'
Language Equivalent   Language Equivalent
French    Spanish
Misspellings - Typos
dosedd,   doses,   dossed,   doosed,   doseed,   sosed,   dpsed,   ddosed,   dosde,   dsoed,   doed,   doded,   dosef,   dosrd,   dose,   fosed,   dsed,   dosd,   dised,   odsed,   doswd,   doesd,   osed,   doaed
Words Starting with Letter - 'A'
a a battery a billion
a bit a bit much a capella singing
a cappella singing a couple of a few
a fortiori a good deal a great deal
a horizon a hundred a hundred and one
a hundred thousand a hundred times a kempis
a la carte a la mode a level
a little a lot a million
Go to Page 1              Go to Page 2 »   
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z